InterMune (ITMN)
InterMune Cash and ST Investments: 377.24M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ITMN Cash and ST Investments Rankings
| Overall | 77th percentile | 984 of 4371 |
| Sector | 85th percentile | 72 of 504 in Healthcare |
| Industry | 90th percentile | 16 of 160 in Biotechnology |
ITMN Cash and ST Investments Range, Past 5 Years
| Minimum | 86.95M | Dec 2009 |
| Maximum | 468.18M | Sep 2011 |
| Average | 218.68M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these ITMN related companies
ITMN News
Of coUrse $ITMN only just broke 10.50 but i think it can get close to 11 today and break of that sends it to mid 11's lwhere it was last wk
about 5 days ago by epime7heus
about 5 days ago by epime7heus
Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT
May 24, 8:39AM Street Insider
May 24, 8:39AM Street Insider
InterMune (ITMN) to divest ActImmune for $55M in cash, plus a two-year royalty stream
May 21, 4:54PM Street Insider
May 21, 4:54PM Street Insider
Intermune Will Divest Rights to Vidara for $55M in Cash, Plus 2 Year Royalty Stream
May 21, 4:52PM Benzinga
May 21, 4:52PM Benzinga
Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Esbriet (pirfenidone) Positive GBA Assessment
May 21, 10:02AM Street Insider
May 21, 10:02AM Street Insider
Quant modell indicates a 2 - 1 chance for $ITMN not closing above 11.56 today. Now trading at 11.41 or +9.3%
about 29 days ago by TradeBot
about 29 days ago by TradeBot
$ITMN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3aRF
about 30 days ago by MarketBrief
about 30 days ago by MarketBrief
@bnichols9883 Don't count $ITMN out; it had a hiccup in sales; not surprising, but I expect a successful P3 trial and US approval in two yrs
about 30 days ago by SlownSteady
about 30 days ago by SlownSteady
$ITMN is -5.9% down since open on unusual high volume and -14.2% down since close.
about 33 days ago by TradeBot
about 33 days ago by TradeBot
Drug Approvals or Rejections have a huge impact on InterMune stock $ITMN, now trading at support level. http://stks.co/3Xsw
about 33 days ago by TradingGraphs
about 33 days ago by TradingGraphs
$ITMN Any thoughts at these levels? Chart looks like it's basing and turning.
about 34 days ago by oddsmaker
about 34 days ago by oddsmaker
Listen to $ITMN Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3XQd
about 34 days ago by earningscast
about 34 days ago by earningscast
InterMune Reports First Quarter 2012 Financial Results And Business Highlights
Apr 26, 4:00PM PR Newswire
Apr 26, 4:00PM PR Newswire
$ITMN http://stks.co/3M1f Watching the support level to see if we hold and bounce or fail ...
about 45 days ago by jamiemc101
about 45 days ago by jamiemc101
UPDATE - UBS Initiates Coverage on Intermune (ITMN) with a Neutral; Overshot to Downside, But Stuck Until More Clarity
Apr 12, 11:13AM Street Insider
Apr 12, 11:13AM Street Insider
Brean Murray Carret & Co. Adjusting Estimates & PT InterMune Inc. (ITMN); Timelines Push Things Back
Apr 10, 8:56AM Street Insider
Apr 10, 8:56AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ITMN | 10.26 | -0.84 | -7.57% | 725.16M |
| ITIC | 51.02 | +0.83 | +1.65% | 105.40M |
| ITI | 1.41 | -0.04 | -2.76% | 48.31M |
| ITC | 68.99 | -0.07 | -0.10% | 3.546B |
| ITA | 62.31 | +0.62 | +1.00% | |
| IT | 40.96 | -0.15 | -0.36% | 3.838B |
| ISTA | 9.095 | -0.01 | -0.05% | 380.11M |
| IST | 20.56 | -0.20 | -0.96% | |
| ISSI | 9.63 | -0.17 | -1.73% | 264.99M |
| ISSC | 3.54 | -0.05 | -1.39% | 58.91M |
